Angel Biotechnology Ltd Signs 450,000 stg Contract with Russia's Materia
LONDON (Thomson Financial) - Angel Biotechnology Holdings PLC said it has signed a contract worth about 450,000 stg with Russia-based Materia Medica Holdings for process development and GMP manufacture of polyclonal antibodies.